Erratum: VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer (Lung Cancer (2003) 46 (293-298) DOI: 10.1016/j.lungcan.2004.04.037);VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer

Lung Cancer

Volumn 46, Issue 3, 2004, Pages 293-298

  Koukourakis, Michael I ^a,b   Papazoglou, Dimitrios ^a   Giatromanolaki, Alexandra ^a   Bougioukas, George ^a   Maltezos, Efstratios ^a   Siviridis, Efthimios ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b Tumor and Angiogenesis Research Group Alexandroupolis   (Greece)

Author keywords

Angiogenesis; Gene polymorphism; Non small cell lung cancer; VEGF

Indexed keywords

VASCULOTROPIN;

ALLELE; ANGIOGENESIS; ARTICLE; CANCER CELL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DENSITY; GENE; GENE EXPRESSION; GENE SEQUENCE; GENETIC LINKAGE; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIAL GROWTH FACTOR GENE;

EID: 8444239305     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2004.11.009     Document Type: Erratum

References (15)

1. Ferrara N., Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr. Rev. 18:1997;4-25
2. Giatromanolaki A., Koukourakis M.I., Sivridis E., O'Byrne K., Cox G., Thorpe P.E., et al. Coexpression of MUC1 glycoprotein with multiple angiogenic factors in non-small cell lung cancer suggests coactivation of angiogenic and migration pathways. Clin. Cancer Res. 6:2000;1917-1921
3. O'Byrne K.J., Koukourakis M.I., Giatromanolaki A., Cox G., Turley H., Steward W.P., et al. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer. Br. J. Cancer. 82:2000;1427-1432
4. Giatromanolaki A., Koukourakis M.I., Sivridis E., O'Byrne K., Gatter K.C., Harris A.L. Invading edge vs. inner (edvin) patterns of vascularisation: an interplay between angiogenic and vascular survival factors defines clinical behaviour of non small cell lung cancer. J. Pathol. 192:2000;140-149
5. Brogan I.J., Khan N., Isaac K., Hutchinson J.A., Pravica V., Hutchinson I.V. Novel polymorphisms in the promoter and 5′ UTR regions of the human vascular endothelial growth factor gene. Hum. Immunol. 60:1999;1245-1249
6. Watson C.J., Webb N.J., Bottomley M.J., Brenchley P.E. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine. 12:2000;1232-1235
7. Renner W., Kotschan S., Hoffmann C., Obermayer-Pietsch B., Pilger E. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J. Vasc. Res. 37:2000;443-448
8. Awata T., Inoue K., Kurihara S., Ohkubo T., Watanabe M., Inukai K., et al. A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes. 51:2002;1635-1639
9. Giatromanolaki A., Koukourakis M., Theodossiou D., Barbatis C., Harris A.L., Gatter K.C. Comparative evaluation of angiogenesis assessment with anti-Factor VIII and anti-CD31 immunostaining in non small cell lung cancer. Clin. Cancer Res. 3:1997;2493-2500
10. Stevens A., Soden J., Brenchley P.E., Ralph S., Ray D.W. Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Res. 63:2003;812-816
11. Howell W.M., Bateman A.C., Turner S.J., Collins A., Theaker J.M. Influence of vascular endothelial growth factor single nucleotide polymorphisms on tumour development in cutaneous malignant melanoma. Genes Immunol. 3:2002;229-232
12. McCarron S.L., Edwards S., Evans P.R., Gibbs R., Dearnaley D.P., Dowe A., et al. Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res. 62:2002;3369-3372
13. 2 homeostasis. Curr. Opin. Genet Dev. 8:1998;588-594
14. Harris A.L. Hypoxia: a key regulatory factor in tumour growth. Nat. Rev. Cancer. 2:2002;38-47
15. Giatromanolaki A., Koukourakis M.I., Sivridis E., Turley H., Talks K., Pezzella F., et al. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival. Br. J. Cancer. 85:2001;881-890